Patents by Inventor David C. Bom

David C. Bom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090030042
    Abstract: A method of making a compound of formula II comprising the reaction of a compound of formula RCONH2 with a compound of formula III R being a moiety having between 1 and 15 carbon atoms and optionally from 1 to 5 heteroatoms independently selected from oxygen, nitrogen and sulfur, and X and Y being independently selected front the group consisting of H, methyl, ethyl, OMe, OEt, and mixtures thereof; the reaction being performed in a solvent in the presence of a base. The method is useful for the inexpensive manufacture of certain commercially-valuable compounds, including some that have desirable cooling properties.
    Type: Application
    Filed: July 15, 2008
    Publication date: January 29, 2009
    Applicant: Givaudan, SA.
    Inventors: Stefan Michael Furrer, David C. Bom, David Max Dastrup, Ioana Maria Ungureanu
  • Publication number: 20080287465
    Abstract: Acrylic n-hydroxy imides and their use in pharmaceutical compositions and in the inhibition of flap endonuclease are disclosed.
    Type: Application
    Filed: July 20, 2005
    Publication date: November 20, 2008
    Applicant: ATHERSYS, INC.
    Inventors: Lawrence N. Tumey, Youssef Bennani, Bayard Huck, David C. Bom
  • Patent number: 7423056
    Abstract: The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).
    Type: Grant
    Filed: September 1, 2005
    Date of Patent: September 9, 2008
    Assignee: Athersys, Inc.
    Inventors: Youssef L. Bennani, David C. Bom, Michael J. Robarge